KBC 87 euro Wedbush 121 $ = 104 euro Piper Jaffray 154 $ = 132 euro JMP Securities 150 $ = 129 euro Stiffel 139 $ = 119,50 euro Nomura 161 $ = 138,40 Kempen en Co 140 euro
STRONG BUY !!!
Recent ARGX News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/19/2024 10:06:23 AM
- argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy • GlobeNewswire Inc. • 09/19/2024 05:00:00 AM
- argenx to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 08/28/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/25/2024 10:01:40 AM
- argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update • GlobeNewswire Inc. • 07/25/2024 05:00:00 AM
- argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024 • GlobeNewswire Inc. • 07/18/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/16/2024 09:22:23 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/16/2024 08:03:55 PM
- argenx and Zai Lab Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China • GlobeNewswire Inc. • 07/16/2024 04:30:00 AM
- Zai Lab and argenx Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China • Business Wire • 07/16/2024 04:15:00 AM
- argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 Peripheral Nerve Society Annual Meeting • GlobeNewswire Inc. • 06/25/2024 08:30:00 PM
- argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy • GlobeNewswire Inc. • 06/21/2024 08:50:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/17/2024 10:05:43 AM
- argenx to unveil its ‘Vision 2030: Taking Breakthrough Science to 50,000 Patients’ during its Upcoming R&D Day on July 16, 2024 • GlobeNewswire Inc. • 06/17/2024 05:00:00 AM
- argenx to Present at Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/04/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/09/2024 11:06:00 AM
- argenx Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/08/2024 10:15:25 AM
- argenx announces results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 05/07/2024 09:30:00 PM
- argenx to Present at BofA Securities 2024 Health Care Conference • GlobeNewswire Inc. • 05/07/2024 05:00:00 AM
- argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024 • GlobeNewswire Inc. • 05/02/2024 05:00:00 AM
- argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease • GlobeNewswire Inc. • 04/16/2024 05:00:00 AM
- argenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Disease • GlobeNewswire Inc. • 03/27/2024 06:00:00 AM
- argenx Announces Annual General Meeting of Shareholders on May 7, 2024 • GlobeNewswire Inc. • 03/26/2024 08:00:00 PM
- argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia • GlobeNewswire Inc. • 03/26/2024 06:00:00 AM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM